The number of COVID-19 cases has reached a record high in mainland China, peaking on 2 December 2022. In the past three weeks, incidence has fallen, likely also due to a lower number of tests being carried out, resulting in fewer infections being detected. ECDC, together with the EU/EEA Member States and the European Commission […]
Read More
The Commission has adopted a proposal to give more time to certify medical devices
The Commission adopted a proposal to give more time to certify medical devices to mitigate the risk of shortages. The proposal introduces a longer transition period to adapt to new rules, as foreseen under the Medical Devices Regulation. The new deadlines depend on the medical devices’ risk class and will ensure continued access to medical […]
Read More
A new EU Health security framework is in motion
On December 25, the building blocks of the European Health Union are officially in place. This not only includes stronger EU rules on serious cross-border threats to health, but also a stronger mandate of the European Centre for Disease Prevention and Control (ECDC) and a new Emergency Framework for medical countermeasures. Taken together with an […]
Read More
EU-UK relations: Commission extends arrangements for veterinary medicines to 2025
The European Commission has today adopted a notice which extends to 31 December 2025 the current arrangements for the movement of veterinary medicines from Great Britain to Cyprus, Ireland, Malta and Northern Ireland. This will ensure the continuity of supplies of veterinary medicinal products, in particular to Northern Ireland. The Commission recognises the key importance of veterinary […]
Read More
European Health Union: new approach on cancer screening
Following the Commission’s proposal to strengthen cancer prevention through early detection, the Council of the European Union has adopted a new approach on cancer screening. This is an important step to improve early detection throughout the EU, an important goal of the Europe’s Beating Cancer Plan. As announced in September, this new EU approach, based on the latest […]
Read More
Evolution of monkeypox in Europe
Monkeypox (MPX) is a zoonotic disease and is currently the most prevalent orthopoxviral infection in humans after the eradication of smallpox and the cessation of universal smallpox vaccination. In endemic areas, monkeypox virus (MPXV) probably circulates among a number of mammals, although there is no known reservoir. Occasional spill-over events to humans generate outbreaks. MPXV […]
Read MoreEvolución de la viruela del mono en Europa
La viruela del mono (MPX) es una enfermedad zoonótica y actualmente es la infección ortopoxviral más prevalente en el ser humano tras la erradicación de la viruela y el cese de la vacunación universal contra la viruela. En las zonas endémicas, el virus de la viruela del mono (MPXV) circula probablemente entre varios mamíferos, aunque […]
Read More
EU Global Health Strategy
The Commission adopted a new EU Global Health Strategy to improve global health security and deliver better health for all in a changing world. With the Strategy, the EU deepens its leadership and reasserts its responsibility for tackling key global challenges and health inequalities head-on: the unfinished agenda in global health and combatting health threats […]
Read More
HERA signs Joint Procurement contract COVID-19 treatments
The Commission’s Health Preparedness and Response Authority (HERA) has signed a joint procurement Framework Contract for the supply of Paxlovid, a SARS-CoV-2 protease inhibitor oral treatment for patients with COVID-19 at risk of developing severe disease. The contract is signed with the pharmaceutical company Pfizer and will run for an initial period of 12 months. Thirteen […]
Read More